F2G Ltd Announces the Appointment of Dr Richard J. White as Chairman of the Board of Directors
F2G also announced the appointment of a new non-executive director, Dr Sten Verland of Sunstone Capital A/S.
"I congratulate Richard on his appointment as Chairman” said Shane M. Kelly, Chief Executive of F2G Ltd. “Richard has a wealth of experience in infectious disease drug discovery gained within Biotech and Pharma. He has been a tremendous asset to the Company during his time on the Board and I look forward to working with him towards the further development of F2G Ltd. The Board also welcomes Dr Sten Verland, whose proven expertise in building successful businesses will be a valuable addition to the team.”
Dr Richard J. White commented ”This an exciting time for F2G as our lead program progresses to clinical testing and I eagerly anticipate working closely with the other Board members".
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.